In the Journals

Hepatitis D coinfection found in ‘household clusters’ in Cameroon

January 17, 2020
Investigation into the epidemiology of hepatitis D in Cameroon revealed intrahousehold infection and large differences in prevalence between regions…

In the Journals

Modified PAGE-B score classifies HCC risk in patients undergoing HBV therapy

January 15, 2020
The PAGE-B score and a modified PAGE-B score identified which patients on antiviral therapy for chronic hepatitis B had a low risk for hepatocellular…

In the Journals

‘Pathway code’ for HCV test orders improves screening, linkage to care

January 13, 2020
Implementation of a multifaceted hepatitis C care pathway improved screening and linkage to care rates, especially among baby boomers, or those born…

8 reports on safety of HCV positive-to-negative organ transplants

January 10, 2020
The “direct-acting antiviral era” for hepatitis C has been a novel step forward in medicine with several regimens providing cure rates of…

In the Journals

Sexually transmitted HCV rates high among MSM regardless of HIV status

January 7, 2020
Researchers found high rates of sexually transmitted hepatitis C among HIV-negative men who have sex with men who used pre-exposure prophylaxis…

In the Journals

HDV has higher health care, cost burden than HBV

January 2, 2020
Hepatitis delta virus has a higher association with health care and cost burden on patients than hepatitis B virus, according to a study by the…

Meeting News

REP2139 demonstrates functional cure in both HBV, HDV

December 26, 2019
Results from the REP 301 and REP 401 studies showed combination therapy with REP2139 and pegylated interferon led to high rates of hepatitis B…

In the Journals

HCV elimination program helps identify infection, begin treatment

December 23, 2019
Georgia’s hepatitis C virus elimination program made significant progress in helping diagnose patients and begin treatment, according to a…

Q&A: Finding a cure for hepatitis B

December 19, 2019
The NIH announced a plan to “intensify” ongoing hepatitis B virus research that is focused on finding a cure and improving screening and…

In the Journals

HCV-positive transplants into aviremic patients safe for multiple organs

December 16, 2019
Data from a large, real-world study contributed to the growing safety and efficacy evidence of transplanting hepatitis C-infected organs into…

In the Journals

Patients with HCV responsive to alcohol intervention

December 12, 2019
Patients with current or prior hepatitis C infection were willing to engage in alcohol intervention including counseling and referral to treatment…

In the Journals

Retreatment for HCV may require switching DAA inhibitor classes

December 10, 2019
Patients who failed to achieve sustained virologic response after initial treatment for hepatitis C achieved high cure rates during retreatment after…

In the Journals

‘Screen all approach’ for HBV prior to chemotherapy most cost-effective

December 6, 2019
Screening all patients with solid tumors for hepatitis B before they underwent chemotherapy was the most cost-effective strategy, compared with not…

6 reports on comorbid renal outcomes in liver disease

November 27, 2019
Patients with liver disease, especially those with advanced liver disease, may face comorbid renal-related complications including impaired renal…

Highlights from The Liver Meeting: 6 reports on viral hepatitis

November 22, 2019
This year’s The Liver Meeting provided many exciting updates for viral hepatitis care ranging from steps toward eliminating hepatitis C to…

Meeting News

Trio Health presents novel HBV, HCV therapy findings at The Liver Meeting

November 22, 2019
Trio Health presented results from four studies at The Liver Meeting 2019 that showed novel outcomes in patients treated for hepatitis B with Vemlidy…

Gilead DAAs safe, effective for adults with HCV, severe renal impairment

November 21, 2019
The FDA approved changes to the product labels for direct-acting antivirals Harvoni, Epclusa, and Vosevi to include new efficacy and safety data for…

Meeting News

‘Building bridges’ between PCPs, liver specialists for HCV led to 100% cure

November 14, 2019
BOSTON — The Hepatitis C Leaders in Primary Care program, or HELP-C, engaged primary care physicians to successfully screen and treat veterans…

Meeting News

‘Quest for better HDV therapy’: triple combination reduces RNA in most

November 13, 2019
BOSTON — Triple combination therapy with lonafarnib, ritonavir, and Lambda for chronic hepatitis D appeared safe and tolerable for up to 6…

Meeting NewsVideo

VIDEO: Novel therapy safe, effective in acute, severe alcoholic hepatitis

November 12, 2019
BOSTON — In this exclusive video from The Liver Meeting 2019, Tarek Hassanein, MD, FAASLD, professor of medicine at UC San Diego Health and…